Typhoid
fever vaccines provide protection against typhoid fever caused by Salmonella
Typhi bacteria. The market has witnessed increased demand for typhoid fever
vaccines owing to the increasing occurrence of typhoid cases worldwide. Typhoid
fever is widely prevalent in parts of Africa, Asia, and Latin America, with
children being at the highest risk of contracting the disease. The global
Typhoid Fever Vaccines Market is estimated to be valued at US$ 454.2 Bn in 2024
and is expected to exhibit a CAGR of 14%
over the forecast period 2024 to 2031, as highlighted in a new report published
by Coherent Market Insights.
Market key trends:
The increasing demand for effective vaccines is one of the major trends
being witnessed in the typhoid fever vaccines market. The widespread prevalence
of typhoid fever across developing parts of the world has boosted research
efforts focused on developing improved vaccines. Traditionally, typhoid
vaccines had lower efficacy and required multiple doses for protection.
However, new single-dose vaccines such as Bharat Biotech’s Typbar-TCV vaccine
have demonstrated higher levels of protection against the disease. Such
advancements are expected to provide a boost to vaccine usage rates globally.
Additionally, successful awareness drives by public health organizations
regarding the importance of vaccination against typhoid fever have also
contributed to the growing demand for these vaccines over the recent past.
Segment Analysis
The
global
typhoid fever vaccines market share is segmented based on vaccine type,
end use and distribution channel. By vaccine type, the Vi capsular
polysaccharide vaccine sub segment dominates the market as it provides strong
immunity against typhoid fever. It induces antibody responses specific to the
Vi capsular polysaccharide that coats Salmonella Typhi and provides
Type-specific protection.
Key Takeaways
The global typhoid fever vaccines market is expected to witness high growth
during the forecast period of 2024 to 2031.
Regional
analysis - Europe is currently the fastest growing region in the typhoid fever
vaccines market. This is due to rising government initiatives to vaccinate
people against typhoid fever in countries like the UK.
Key
players operating in the typhoid fever vaccines market are Linde Plc, Air
Liquide, Engie, Uniper Se, Air Products Inc, Clean Hydrogen System, Cummins
Inc., Toshiba Energy Systems & Solutions Corporation, Nel Asa, and Sgh2
Energy.
Comments
Post a Comment